Consensus statement on safety measures for pressurized intraperitoneal aerosol chemotherapy
暂无分享,去创建一个
O. Sgarbura | M. Hübner | M. Reymond | L. Villeneuve | M. Alyami | D. Clerc | A. Girardot-Miglierina
[1] B. Rau,et al. Current practice and perceptions of safety protocols for the use of intraperitoneal chemotherapy in the operating room: results of the IP-OR international survey , 2021, Pleura and Peritoneum.
[2] M. Lahaye,et al. Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC) , 2021, Annals of Surgical Oncology.
[3] M. Pocard,et al. Standardizing training for Pressurized Intraperitoneal Aerosol Chemotherapy. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[4] O. Sgarbura,et al. Non-medical caregivers and the use of intraperitoneal chemotherapy in the operating theatre: A survey on the perception of safety. , 2020, Journal of visceral surgery.
[5] D. Lobo,et al. Recommendations from the ERAS® Society for standards for the development of enhanced recovery after surgery guidelines , 2019, BJS open.
[6] P. Diemunsch,et al. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow. , 2019, Journal of visceral surgery.
[7] F. Lordick,et al. [Perioperative safety of intraperitoneal aerosol chemotherapy : Analysis of our first 111 pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures]. , 2019, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[8] G. Nadiradze,et al. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) , 2019 .
[9] S. Ndaw,et al. Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination. , 2018, Toxicology letters.
[10] D. Nowak,et al. Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)? , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[11] C. Tempfer,et al. How to Perform Safe and Technically Optimized Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Experience After a Consecutive Series of 1200 Procedures , 2018, Journal of Gastrointestinal Surgery.
[12] O. Glehen,et al. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video) , 2018, Journal of Gastrointestinal Surgery.
[13] P. Sessink,et al. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) , 2017, Pleura and peritoneum.
[14] N. Demartines,et al. Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[15] N. Demartines,et al. Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis , 2017, The British journal of surgery.
[16] M. Mortensen,et al. Environmental safety during the administration of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) , 2016, Pleura and peritoneum.
[17] J. Spiliotis,et al. Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC). , 2016, Surgical oncology.
[18] W. Solass,et al. [Occupational Health Aspects of Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC): Confirmation of Harmlessness]. , 2014, Zentralblatt fur Chirurgie.
[19] S. Msika,et al. Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[20] Urs Giger-Pabst,et al. Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy , 2013, Annals of Surgical Oncology.
[21] David Rind,et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. , 2013, Journal of clinical epidemiology.
[22] W. Solass,et al. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects , 2013, Annals of Surgical Oncology.
[23] D. Nowak,et al. Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC). , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.